Attached files

file filename
8-K - FORM 8-K - PRO DEX INCd465220d8k.htm

Exhibit 99.1

 

LOGO

Contact: Michael J. Berthelot, Chief Executive Officer

(949) 769-3200                        

For Immediate Release

PRO-DEX, INC. ANNOUNCES FISCAL SECOND QUARTER AND SIX-MONTH RESULTS

IRVINE, CA, January 10, 2013—PRO-DEX, INC. (NasdaqCM: PDEX) today announced financial results for its fiscal second quarter and six months ended December 31, 2012.

Quarter Ended December 31, 2012

Sales for the quarter ended December 31, 2012 decreased 25% to $3.0 million from $4.0 million for the corresponding quarter in 2011. As the Company has previously discussed, this decrease was primarily the result of reductions in purchases of the Company’s powered surgical instrument products by its former largest customer, partially offset by increases in such surgical instrument sales to other customers. Excluding sales to the Company’s former largest customer, which represented a reduction of $1.5 million in the quarter ended December 31, 2012 from the corresponding quarter in 2011, sales increased $524,000, or 25%, in the quarter ended December 31, 2012.

Gross profit for the quarter ended December 31, 2012 was $1.0 million, or 34%, compared to gross profit of $1.2 million, or 31%, for the year-ago period. The increase in gross profit as a percentage of sales from 2011 to 2012 was due primarily to a reduction in warranty costs and improvements in manufacturing efficiencies, partially offset by unfavorable changes in product mix.

Operating expenses, which include selling, general and administrative, and research and development expenses, for the quarter ended December 31, 2012 decreased 10% to $1.4 million from $1.6 million in the prior year’s corresponding quarter. This decrease was attributable to the effects of reduced employee compensation, other operating expense cuts, and the utilization of engineering resources in contractual revenue-producing activities. Included in operating expenses for the quarter ended December 31, 2012 was $42,000 of legal and other costs associated with the contested election of directors, without which such costs the reduction in operating expenses would have been 12%.

Loss from continuing operations for the quarter ended December 31, 2012 was $364,000, compared to a loss from continuing operations of $329,000 in the corresponding quarter in 2011. Net loss for the quarter ended December 31, 2012 was $348,000, or $0.11 per diluted share, compared to a net loss of $292,000, or $0.09 per diluted share, for the corresponding quarter in 2011. Earnings before interest, income taxes and depreciation (“EBITDA”) for the quarter ended December 31, 2012 was a loss of $196,000, compared to a loss of $130,000 in the corresponding quarter in 2011.

During the quarter ended December 31, 2012, the Company used $619,000 of cash in operating activities. This use of cash reflects primarily payments made in the second fiscal quarter for the build-up of inventory in first fiscal quarter in anticipation of customer orders and pursuant to the Company’s operating plan, one of the foundational objectives of which is to reduce production lead times.


Six Months Ended December 31, 2012

Sales for the six months ended December 31, 2012 decreased 29% to $6.5 million from $9.1 million in the corresponding six-month period in 2011. Excluding sales to the Company’s former largest customer, which represented a reduction of $3.8 million in the six months ended December 31, 2012 from the corresponding period in 2011, sales for the six months ended December 31, 2012 increased $1.2 million, or 25%, in the six months ended December 31, 2012. During the six months ended December 31, 2012, the Company received new orders of $9.4 million, compared to $2.8 million in the corresponding period in 2011, excluding orders received from the former largest customer. The book to bill ratio for the six months ended December 31, 2012 was 1.5.

For the six months ended December 31, 2012, gross profit was $2.3 million, or 35%, compared to $3.4 million and 37%, respectively, for the corresponding period in 2011. The decrease in gross profit as a percentage of sales from 2011 to 2012 resulted primarily from reduced manufacturing efficiencies and unfavorable changes in product mix, partially offset by a reduction in warranty costs.

Operating expenses for the six months ended December 31, 2012 decreased 19% to $2.7 million, from $3.3 million in the corresponding six-month period of 2011. This decrease was attributable to the effects of reduced employee compensation, other operating expense cuts, and the utilization of engineering resources in contractual revenue-producing activities.

For the six months ended December 31, 2012, loss from continuing operations was $418,000, compared to income from continuing operations of $17,000 for the corresponding period in 2011. Net loss for the 2012 six-month period was $365,000, or $0.11 per diluted share, as compared to net income of $154,000, or $0.05 per diluted share, for the corresponding period in 2011. EBITDA for the six months ended December 31, 2012 was a loss of $55,000, compared to income of $473,000 in the corresponding period one year ago.

During the six months ended December 31, 2012, the Company used $791,000 of cash in operating activities. This use of cash reflects primarily the previously mentioned build-up of inventory in first fiscal quarter. In addition, as announced previously, in September 2012 the Company repaid the entire outstanding balance on the term loan from Union Bank amounting to $685,000. As a result of the foregoing, cash on hand at December 31, 2012 was $2.5 million, compared to $4.1 million at June 30, 2012.

Michael J. Berthelot, the Company’s President and Chief Executive Officer, commented, “We believe that the results of the quarter and six months ended December 31, 2012 reflect continued progress on our strategy to move our company forward. We believe that our continuing efforts to attract, quote on and win new business are showing results. In the six months ended December 31, 2011, the first half of fiscal year 2012, we submitted five proposals to potential customers, and submitted eight proposals for the entire fiscal year. So far in this current fiscal year we have already submitted eight proposals in the six months ended December 31, 2012 and have won one of them. As important, the value of the current year proposals in both non-recurring engineering and production value materially exceed those from last year. While we can offer no assurances that we will win any of the business upon which we have quoted, we know that we cannot win any business on which we do not quote. We continue to win business from new customers as well as current customers, as shown in a 25% increase in sales of powered surgical instruments to customers other than our former largest customer compared to last year’s corresponding quarter and six-months, and continue to build our backlog with a book to bill ratio of 1.5 for both the quarter and the six months ended December 31, 2012.”

“Our continuing efforts at cost reduction and improved manufacturing efficiencies led to our gross margin for the quarter ended December 31, 2012 increasing to 34% from 31% in last year’s corresponding quarter in spite of a 25% reduction in sales volume and an unfavorable shift in product mix,” said Mr. Berthelot. “Our programs to reduce cost in every non-manufacturing department continue to bear fruit, as evidenced by the 10% reduction in operating costs for the quarter from last year. It is important to point out that $42,000 of the general and administrative costs for the quarter are associated with the contested election of directors that we would not normally incur.”


Mr. Berthelot said, “With respect to product innovation and quality improvement, much of the new proposals discussed above revolve around our Pro-Driver platform and involve various derivatives and modifications to our basic product. While the time-consuming process from initial meeting to proposal, development, testing, acceptance and production may run from twelve to eighteen months and involve resources from sales and marketing, engineering, quality assurance, operations and finance, we have achieved success in winning customer acceptance of our development process and we hope that success will continue on if and when the product is released to production. We have been working on an expansion of our dental product line for several months. With a resurgent marketing effort, we hope to launch a new product that will fill out our dental product line during the next six months. As we push forward our product innovation and development efforts and move to protect our intellectual property, we are seeing greater spending on legal fees associated with patent and trademark filings, which aggregated $22,000 and $47,000 during the quarter and six months ended December 31, 2012, respectively.”

Mr. Berthelot continued, “Lead times for our most significant products continue to improve. As a result of a change in our production and planning processes, we are now able to ship our standard Pro-Drivers, the product which is currently attracting the most interest from potential customers, within two days of order for small volumes and two weeks for larger volumes, compared to quoted lead times of sixteen weeks in last fiscal year’s fourth quarter. We believe that an improved responsiveness to customer requests for samples and small volume test and evaluation lots will help us in our efforts to participate from the early phases of new customer programs.”

“While we are making progress, we still have much to do. The second quarter was, we believe, the toughest of the fiscal year, partly due to our shutdown of operations for two weeks during the quarter for the Thanksgiving, Christmas and New Year holidays as part of our cost reduction program. Our backlog is strong for the second half of fiscal 2013. We expect to continue to press down on our cost structure while increasing engineering resources. We expect the programs and projects that we have begun to move our company forward and to build value for every shareholder.”

“Of course,” Mr. Berthelot noted, “we appreciate the support of each and every shareholder as we pursue our strategy amidst the distraction and diversion of resources due to the contested election of directors. We understand that there have been some logistical problems in our proxy materials arriving to our shareholders on the West Coast. If you have not yet received the Company’s proxy materials which include the BLUE proxy card, we encourage you to contact our proxy solicitor, AST Phoenix Advisers, at 1-866-721-1318 and ask for the materials to be sent to you. We ask that all of our shareholders vote for the Pro-Dex director nominees using the BLUE proxy card as quickly as possible, and we thank you for your support.”

Teleconference Information:

Investors and analysts are invited to listen to a broadcast review of the Company’s fiscal 2013 second quarter and six-month financial results today at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) that may be accessed by visiting the Company’s website at www.pro-dex.com. The conference call may also be accessed at www.InvestorCalendar.com. Investors and analysts who would like to participate in the conference call may do so via telephone at (877) 407-8033, or at (201) 689-8033 if calling from outside the U.S. or Canada.

For those who cannot access the live broadcast, a replay will be available approximately two hours after the completion of the call until midnight (Eastern Time) on January 24, 2013 by calling (877) 660-6853, or (201) 612-7415 if calling from outside the U.S. or Canada, and then entering conference I.D. number 407053. An online archive of the broadcast will be available on the Company’s website www.pro-dex.com for a period of 365 days.


About Pro-Dex, Inc.:

Pro-Dex, Inc., with operations in California and Oregon, specializes in the design, development and manufacture of powered rotary drive surgical and dental instruments used primarily in the orthopedic, spine, maxocranial facial and dental markets. Its OMS division designs and manufactures embedded motion control systems serving the medical, dental, semi-conductor and scientific research markets. Pro-Dex’s products are found in hospitals, dental offices, medical engineering labs, scientific research facilities and high tech manufacturing operations around the world. For more information, visit the Company’s website at www.pro-dex.com.

Statements herein concerning the Company’s plans, growth and strategies may include ‘forward-looking statements’ within the context of the federal securities laws. Statements regarding the Company’s future events, developments and future performance, as well as management’s expectations, beliefs, plans, estimates or projections relating to the future, are forward-looking statements within the meaning of these laws. The Company’s actual results may differ materially from those suggested as a result of various factors. Interested parties should refer to the disclosure concerning the operational and business concerns of the Company set forth in the Company’s filings with the Securities and Exchange Commission.

(tables follow)


PRO-DEX, INC. and SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

 

     December 31, 2012     June 30, 2012  

ASSETS

    

Current assets:

    

Cash

   $ 2,549,000      $ 4,112,000   

Accounts receivable, net of allowance for doubtful accounts of $13,000 at December 31, 2012 and $16,000 at June 30, 2012

     1,175,000        1,581,000   

Other current receivables

     90,000        123,000   

Inventories

     3,515,000        2,791,000   

Prepaid expenses

     237,000        172,000   

Income taxes receivable

     570,000        609,000   

Deferred income taxes

     109,000        109,000   
  

 

 

   

 

 

 

Total current assets

     8,245,000        9,497,000   

Property, plant, equipment and leasehold improvements, net

     2,290,000        2,539,000   

Real estate held for sale

     733,000        733,000   

Other assets

     53,000        53,000   
  

 

 

   

 

 

 

Total assets

   $ 11,321,000      $ 12,822,000   
  

 

 

   

 

 

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

    

Current liabilities:

    

Accounts payable

   $ 576,000      $ 633,000   

Accrued expenses

     1,008,000        1,425,000   

Income taxes payable

     47,000        47,000   

Bank term loan

     —          774,000   
  

 

 

   

 

 

 

Total current liabilities

     1,631,000        2,879,000   
  

 

 

   

 

 

 

Non-current liabilities:

    

Deferred income taxes

     109,000        109,000   

Deferred rent

     280,000        284,000   
  

 

 

   

 

 

 

Total non-current liabilities

     389,000        393,000   
  

 

 

   

 

 

 

Total liabilities

     2,020,000        3,272,000   
  

 

 

   

 

 

 

Commitments and contingencies

    

Shareholders’ equity:

    

Common shares; no par value; 50,000,000 shares authorized; 3,340,684 and 3,272,350 shares issued and outstanding at December 31, 2012 and June 30, 2012, respectively

     16,962,000        16,846,000   

Accumulated deficit

     (7,661,000     (7,296,000
  

 

 

   

 

 

 

Total shareholders’ equity

     9,301,000        9,550,000   
  

 

 

   

 

 

 

Total liabilities and shareholders’ equity

   $ 11,321,000      $ 12,822,000   
  

 

 

   

 

 

 


PRO-DEX, INC. and SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

 

     For The Three Months Ended December 31,  
     2012     2011  

Net sales

   $ 3,007,000      $ 4,017,000   

Cost of sales

     1,974,000        2,770,000   
  

 

 

   

 

 

 

Gross profit

     1,033,000        1,247,000   
  

 

 

   

 

 

 

Operating expenses:

    

Selling expenses

     322,000        369,000   

General and administrative expenses

     627,000        688,000   

Research and development costs

     464,000        508,000   
  

 

 

   

 

 

 

Total operating expenses

     1,413,000        1,565,000   
  

 

 

   

 

 

 

Loss from continuing operations before items below

     (380,000     (318,000
  

 

 

   

 

 

 

Other expense:

    

Interest expense

     —          (10,000
  

 

 

   

 

 

 

Total other expense

     —          (10,000
  

 

 

   

 

 

 

Loss from continuing operations before provision for (benefit from) income taxes

     (380,000     (328,000

Provision for (benefit from) income taxes

     (16,000     1,000   
  

 

 

   

 

 

 

Loss from continuing operations

     (364,000     (329,000

Income from discontinued operations, net of provision for income taxes of $21,000 in 2012 and $0 in 2011

     16,000        37,000   
  

 

 

   

 

 

 

Net loss

   $ (348,000   $ (292,000
  

 

 

   

 

 

 

Per share data:

    

Loss from continuing operations

    

Basic

   $ (0.11   $ (0.10

Diluted

   $ (0.11   $ (0.10

Income from discontinued operations

    

Basic

   $ —        $ 0.01   

Diluted

   $ —        $ 0.01   

Net loss

    

Basic

   $ (0.11   $ (0.09

Diluted

   $ (0.11   $ (0.09

Weighted average shares outstanding—basic

     3,319,180        3,272,350   

Weighted average shares outstanding—diluted

     3,319,180        3,272,350   


PRO-DEX, INC. and SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

 

     For The Six Months Ended December 31,  
     2012     2011  

Net sales

   $ 6,468,000      $ 9,062,000   

Cost of sales

     4,199,000        5,707,000   
  

 

 

   

 

 

 

Gross profit

     2,269,000        3,355,000   
  

 

 

   

 

 

 

Operating expenses:

    

Selling expenses

     596,000        743,000   

General and administrative expenses

     1,234,000        1,504,000   

Research and development costs

     870,000        1,069,000   
  

 

 

   

 

 

 

Total operating expenses

     2,700,000        3,316,000   
  

 

 

   

 

 

 

Income (loss) from continuing operations before items below

     (431,000     39,000   
  

 

 

   

 

 

 

Other expense:

    

Interest expense

     (6,000     (20,000
  

 

 

   

 

 

 

Total other expense

     (6,000     (20,000
  

 

 

   

 

 

 

Income (loss) from continuing operations before provision for (benefit from) income taxes

     (437,000     19,000   

Provision for (benefit from) income taxes

     (19,000     2,000   
  

 

 

   

 

 

 

Income (loss) from continuing operations

     (418,000     17,000   

Income from discontinued operations, net of provision for income taxes of $25,000 in 2012 and $0 in 2011

     53,000        137,000   
  

 

 

   

 

 

 

Net income (loss)

   $ (365,000   $ 154,000   
  

 

 

   

 

 

 

Per share data:

    

Income (loss) from continuing operations

    

Basic

   $ (0.13   $ 0.01   

Diluted

   $ (0.13   $ 0.01   

Income from discontinued operations

    

Basic

   $ 0.02      $ 0.04   

Diluted

   $ 0.02      $ 0.04   

Net income (loss)

    

Basic

   $ (0.11   $ 0.05   

Diluted

   $ (0.11   $ 0.05   

Weighted average shares outstanding—basic

     3,299,379        3,272,350   

Weighted average shares outstanding—diluted

     3,299,379        3,292,508   

 


PRO-DEX, INC. and SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

 

     For The Six Months Ended December 31,  
     2012     2011  

Cash flows from operating activities:

    

Net income (loss)

   $ (365,000   $ 154,000   

Adjustments to reconcile net income (loss) to net cash used in operating activities:

    

Depreciation and amortization

     298,000        339,000   

Allowance for doubtful accounts

     (3,000     6,000   

Share-based compensation

     65,000        33,000   

Changes in:

    

Accounts receivable and other current receivables

     440,000        834,000   

Inventories

     (724,000     (1,030,000

Prepaid expenses

     (65,000     (88,000

Other assets

     —          8,000   

Accounts payable and accrued expenses

     (476,000     (213,000

Income taxes receivable and payable

     39,000        (49,000
  

 

 

   

 

 

 

Net cash used in operating activities

     (791,000     (6,000
  

 

 

   

 

 

 

Cash flows from investing activities:

    

Purchases of equipment

     (48,000     (237,000
  

 

 

   

 

 

 

Net cash used in investing activities

     (48,000     (237,000
  

 

 

   

 

 

 

Cash flows from financing activities:

    

Proceeds from exercise of stock options

     50,000        —     

Principal payments on term loan

     (774,000     (179,000
  

 

 

   

 

 

 

Net cash used in financing activities

     (724,000     (179,000
  

 

 

   

 

 

 

Net decrease in cash

     (1,563,000     (422,000

Cash, beginning of period

     4,112,000        4,689,000   
  

 

 

   

 

 

 

Cash, end of period

   $ 2,549,000      $ 4,267,000   
  

 

 

   

 

 

 

Supplemental Information

    

Cash payments for interest

   $ 9,000      $ 10,000   

Cash payments for income taxes

   $ —        $ —     


PRO-DEX, INC. AND SUBSIDIARIES

RECONCILIATION OF NON-GAAP DATA TO GAAP DATA

Loss From Continuing Operations Before Provision For Income Taxes

(in thousands)

(unaudited)

 

     For The Three Months Ended
December 31,
    For The Six Months Ended
December 31,
 
     2012     2011     2012     2011  

Earnings before interest, taxes, depreciation and amortization (“EBITDA”)

   $ (196,000   $ (130,000   $ (55,000   $ 473,000   

Interest expense

     —          10,000        6,000        20,000   

Depreciation and amortization

     147,000        151,000        298,000        297,000   

Income from discontinued operations, before provision for income taxes of $21,000 and $25,000 for the three and six months ended December 31, 2012, respectively, and $0 for each of the three and six months ended December 31, 2011

     37,000        37,000        78,000        137,000   
  

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) from continuing operations before provision for income taxes

   $ (380,000   $ (328,000   $ (437,000   $ 19,000